Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 03/21/2025 | CALL | $1,000.00 | 4,581 | +1,157 | +33.79% |
| 12/19/2025 | CALL | $1,000.00 | 610 | +310 | +103.33% |
| 02/28/2025 | CALL | $900.00 | 723 | +178 | +32.66% |
| 02/21/2025 | PUT | $700.00 | 1,173 | +163 | +16.14% |
| 02/21/2025 | PUT | $850.00 | 1,220 | +160 | +15.09% |
| 02/21/2025 | CALL | $885.00 | 705 | +141 | +25.00% |
| 02/21/2025 | CALL | $905.00 | 989 | -43 | -4.17% |
| 02/21/2025 | PUT | $760.00 | 441 | -45 | -9.26% |
| 02/21/2025 | PUT | $800.00 | 977 | -46 | -4.50% |
| 03/21/2025 | CALL | $820.00 | 361 | -56 | -13.43% |
| 02/21/2025 | PUT | $670.00 | 1,276 | -81 | -5.97% |
| 02/21/2025 | CALL | $900.00 | 2,617 | -181 | -6.47% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
| Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
| Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
| Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
| SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
| Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
| iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
| Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
| Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
| Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
3 Magnificent Growth Stocks to Buy Right Now
02/22 06:47 am
The Motley Fool
Read moreEvolving Landscape of Obesity: Key Market Insights of Latest Published Different Types of Obesity | DelveInsight
02/21 02:00 pm
GlobeNewswire Inc.
Read moreHyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034
02/21 11:00 am
GlobeNewswire Inc.
Read moreWhy Hims & Hers Stock Dropped Today
02/20 03:25 pm
The Motley Fool
Read moreDigging Into What Hershey and Eli Lilly Told Investors
02/19 10:22 am
The Motley Fool
Read moreBIOA COURT NEWS: BioAge Labs has been Sued for Securities Violations; Contact BFA Law by March 10 if You Lost Money (NASDAQ:BIOA)
02/16 08:18 am
GlobeNewswire Inc.
Read moreWill Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
02/14 04:21 pm
Investing.com
Read moreNovo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon
02/14 08:45 am
The Motley Fool
Read more3 Stocks That Missed on Earnings, but Are Set to Rebound Next Quarter
02/11 08:18 am
Investing.com
Read more2 Growth Stocks to Buy Hand Over Fist in February
02/09 10:10 am
The Motley Fool
Read more2 Stocks That Could Soar Again in 2025
02/08 09:50 am
The Motley Fool
Read moreIs Novo Nordisk Stock a Buy Now?
02/08 07:01 am
The Motley Fool
Read moreMagnificent Seven Slip, Inflation Fears Grip Consumers, Gold Hits Record Highs: This Week In The Markets
02/07 05:41 pm
Benzinga
Read moreParesthesia Treatment Market Outlook: USD 8.0 Billion by 2034, Growing with an Aging Population and Rising Healthcare Expenditures | Analysis by TMR
02/07 12:39 pm
GlobeNewswire Inc.
Read moreWhy Eli Lilly Stock Popped on Thursday
02/06 12:29 pm
The Motley Fool
Read moreForget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
02/02 10:45 am
The Motley Fool
Read moreWith Zepbound Not Matching Expectations, Should Investors Give Up on Eli Lilly?
02/02 09:05 am
The Motley Fool
Read moreThis Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?
02/02 07:36 am
The Motley Fool
Read moreGot $1,000? 2 Top Growth Stocks to Buy Right Now
02/02 05:38 am
The Motley Fool
Read more3 Unstoppable Stocks You Can Buy and Hold for the Rest of Your Life
02/01 09:45 am
The Motley Fool
Read moreFDA Approval of Eli Lilly’s Omvoh for Crohn’s Disease Adds a New Option, but Uptake May be Hampered by US Gastroenterologists’ Brand Preferences Among the IL-23 Class, According to Spherix Global Insights
01/31 02:52 pm
GlobeNewswire Inc.
Read moreBiological Drugs Strategic Research Report 2024-2030, Profiles of 45+ Players Including Abbott Laboratories, Amgen, Baxter, Biogen, BMS, Eli Lilly and Co, GSK, Merck, Novartis, and Pfizer
01/27 11:49 am
GlobeNewswire Inc.
Read moreGot $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
01/25 12:15 pm
The Motley Fool
Read moreMove Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
01/25 08:45 am
The Motley Fool
Read moreWhy Novo Nordisk Stock Jumped a Lucky 7.7% Today
01/24 12:38 pm
The Motley Fool
Read more3 Richly Valued Stocks I'll Be Watching Like a Hawk in 2025
01/24 09:45 am
The Motley Fool
Read more2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher
01/24 05:15 am
The Motley Fool
Read moreMy Top 5 Stocks to Buy in Early 2025
01/23 05:15 am
The Motley Fool
Read moreThis Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?
01/22 05:10 am
The Motley Fool
Read moreWill Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
01/21 06:47 am
The Motley Fool
Read morePain Management Therapeutics Market Is Expected To Reach Revenue Of USD 120.7 Bn By 2033, At 3.9% CAGR: Dimension Market Research.
01/20 10:55 am
GlobeNewswire Inc.
Read more3 Unstoppable Stocks to Buy in 2025
01/18 07:40 am
The Motley Fool
Read moreIs Novo Nordisk Stock a Buy?
01/18 06:32 am
The Motley Fool
Read moreFDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
01/17 09:00 am
Benzinga
Read moreWant Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
01/17 08:30 am
The Motley Fool
Read more7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - Synergistic Rise of Pumps, CGMs, and Ultra-rapid-acting Insulins in T1D Management
01/17 05:53 am
GlobeNewswire Inc.
Read moreCould Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025?
01/17 05:05 am
The Motley Fool
Read moreMy 10 Top Stocks to Buy to Start the New Year Off Right
01/16 04:15 am
The Motley Fool
Read moreEli Lilly Adjusts Outlook, CEO David Ricks Explains Revenue Shortfall
01/15 03:21 pm
Benzinga
Read moreHas Eli Lilly Stock Peaked?
01/15 09:15 am
The Motley Fool
Read moreWhy Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
01/14 01:11 pm
The Motley Fool
Read moreEli Lilly Scoops Up Scorpion Therapeutics' Early-Stage Cancer Program For $2.5 Billion
01/13 11:20 am
Benzinga
Read moreObesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
01/09 03:12 pm
Benzinga
Read moreNUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries
01/09 11:53 am
GlobeNewswire Inc.
Read moreMedicare To Cover Eli Lilly's Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment
01/09 10:16 am
Benzinga
Read more3 Stocks to Buy for 2025 That Are Practically Money Machines
01/09 05:34 am
The Motley Fool
Read moreThis Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly
01/08 10:45 am
The Motley Fool
Read morePrediction: These 3 Healthcare Stocks Will Soar in 2025
01/04 07:48 am
The Motley Fool
Read moreShould You Buy the Dip in Novo Nordisk Stock Right Now?
01/02 09:30 am
The Motley Fool
Read more